These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1408138)

  • 1. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity.
    Nair AP; Hirsch HH; Moroni C
    Oncogene; 1992 Oct; 7(10):1963-72. PubMed ID: 1408138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
    Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
    Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-promoting phorbol ester and activated Ha-ras synergistically reduce the interleukin 3 requirement in a mast cell line.
    Imber R; Fabbro D
    Cancer Res; 1991 Jan; 51(2):632-8. PubMed ID: 1985780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line.
    Buckley MG; Williams CM; Thompson J; Pryor P; Ray K; Butterfield JH; Coleman JW
    Immunology; 1995 Mar; 84(3):410-5. PubMed ID: 7751024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
    Stoecklin G; Gross B; Ming XF; Moroni C
    Oncogene; 2003 Jun; 22(23):3554-61. PubMed ID: 12789264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for oncogenic regulators in an autocrine tumor model using differential display PCR: identification of novel candidate genes including the calcium channel mtrp6.
    Buess M; Engler O; Hirsch HH; Moroni C
    Oncogene; 1999 Feb; 18(7):1487-94. PubMed ID: 10050885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene.
    Castelli C; Sensi M; Lupetti R; Mortarini R; Panceri P; Anichini A; Parmiani G
    Cancer Res; 1994 Sep; 54(17):4785-90. PubMed ID: 8062279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global analysis of differential gene expression after transformation with the v-H-ras oncogene in a murine tumor model.
    Brem R; Certa U; Neeb M; Nair AP; Moroni C
    Oncogene; 2001 May; 20(22):2854-8. PubMed ID: 11420697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.
    Diamantis ID; Nair AP; Hirsch HH; Moroni C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9299-302. PubMed ID: 2512578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA.
    Nair AP; Hahn S; Banholzer R; Hirsch HH; Moroni C
    Nature; 1994 May; 369(6477):239-42. PubMed ID: 8183344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrations in interleukin-1 expression in oncogene-transformed fibrosarcoma lines: constitutive interleukin-1 alpha transcription and manifestation of biological activity.
    Douvdevani A; Huleihel M; Segal S; Apte RN
    Eur Cytokine Netw; 1991; 2(4):257-64. PubMed ID: 1756231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production.
    Nair AP; Diamantis ID; Conscience JF; Kindler V; Hofer P; Moroni C
    Mol Cell Biol; 1989 Mar; 9(3):1183-90. PubMed ID: 2498644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras.
    Guo X; Schrader KA; Xu Y; Schrader JW
    Oncogene; 2005 Mar; 24(14):2330-42. PubMed ID: 15735740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. Analysis of single cells by polymerase chain reaction.
    Razin E; Leslie KB; Schrader JW
    J Immunol; 1991 Feb; 146(3):981-7. PubMed ID: 1824852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of IL-7 and v-Ha-ras in the in vitro neoplastic progression of murine pre-B cells.
    Chen SC; Redenius D; Young JC; Schwartz RC
    Oncogene; 1993 Aug; 8(8):2119-25. PubMed ID: 8336938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts.
    Hajnal A; Klemenz R; Schäfer R
    Cancer Res; 1993 Oct; 53(19):4670-5. PubMed ID: 7691400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras oncogenes amplify lymphokine (interleukin 3, granulocyte-macrophage colony-stimulating factor) induction by calcium ionophore.
    Hahn S; Wodnar-Filipowicz A; Nair AP; Moroni C
    Oncogene; 1991 Dec; 6(12):2327-32. PubMed ID: 1722572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
    Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
    Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.